# Koninklijke Philips NV: overview PHG · NYSE · CIK 313216 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/phg.md) · [Financials](/companies/phg/financials.md) · [Filings](/companies/phg/filings.md) · [Insiders](/companies/phg/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [17.2](/filings/0000313216-24-000003.md) | [17.8](/filings/0000313216-25-000009.md) | [18.2](/filings/0001628280-26-009470.md) | [18.0](/filings/0001628280-26-009470.md) | [17.8](/filings/0001628280-26-009470.md) | | Gross margin | % | [41.8%](/filings/0000313216-24-000003.md) | [40.4%](/filings/0000313216-25-000009.md) | [41.0%](/filings/0001628280-26-009470.md) | [43.1%](/filings/0001628280-26-009470.md) | [45.2%](/filings/0001628280-26-009470.md) | | Operating margin | % | [3.2%](/filings/0000313216-24-000003.md) | [(8.6%)](/filings/0000313216-25-000009.md) | [(0.6%)](/filings/0001628280-26-009470.md) | [2.9%](/filings/0001628280-26-009470.md) | [8.0%](/filings/0001628280-26-009470.md) | | Net margin | % | [19.3%](/filings/0000313216-24-000003.md) | [(9.0%)](/filings/0000313216-25-000009.md) | [(2.6%)](/filings/0001628280-26-009470.md) | [(3.9%)](/filings/0001628280-26-009470.md) | [5.0%](/filings/0001628280-26-009470.md) | | Diluted EPS | $ per share | [3.50](/filings/0000313216-24-000003.md) | [(1.69)](/filings/0000313216-25-000009.md) | [(0.49)](/filings/0001628280-26-009470.md) | [(0.75)](/filings/0001628280-26-009470.md) | [0.93](/filings/0001628280-26-009470.md) | | Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/phg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Mondrian Investment Partners LTD](/funds/1317724.md) | 2026-06-30 | $219.4m | 8,067,528 | | Added +270,406 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $118.0m | 4,340,691 | | Reduced −43,164 | | [FIDUCIARY MANAGEMENT INC /WI/](/funds/764532.md) | 2026-06-30 | $94.1m | 3,459,961 | | Reduced −1,516,952 | | [CAUSEWAY CAPITAL MANAGEMENT LLC](/funds/1165797.md) | 2026-06-30 | $83.3m | 3,061,962 | | Added +605,772 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $79.8m | 2,935,662 | | Added +159,457 | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $72.2m | 2,654,029 | | Reduced −69,775 | | [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $60.1m | 2,210,252 | | Added +221,329 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $56.7m | 2,085,496 | | Added +18,729 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $54.3m | 1,995,282 | | Added +537,732 | | [ENVESTNET ASSET MANAGEMENT INC](/funds/1407543.md) | 2026-06-30 | $35.3m | 1,297,945 | | Added +25,684 | ## Recent filings [All 588 filings](/companies/phg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-21 | 15:03 ET | [SCHEDULE 13D/A](/filings/0001193125-26-360944.md) | Ownership report, active investor, amended | 0001193125-26-360944 | | 2026-07-28 | 06:11 ET | [6-K](/filings/0001628280-26-049913.md) | Report of a foreign private issuer, period 2026-06-30 | 0001628280-26-049913 | | 2026-06-02 | 09:23 ET | [6-K](/filings/0001628280-26-039686.md) | Report of a foreign private issuer, period 2026-06-02 | 0001628280-26-039686 | | 2026-05-08 | 09:51 ET | [6-K](/filings/0001628280-26-032599.md) | Report of a foreign private issuer, period 2026-05-08 | 0001628280-26-032599 | | 2026-05-06 | 09:01 ET | [6-K](/filings/0001628280-26-030945.md) | Report of a foreign private issuer, period 2026-03-31 | 0001628280-26-030945 | | 2026-03-30 | 11:06 ET | [6-K](/filings/0001628280-26-021906.md) | Report of a foreign private issuer, period 2026-03-23 | 0001628280-26-021906 | | 2026-03-30 | 11:02 ET | [6-K](/filings/0001628280-26-021903.md) | Report of a foreign private issuer, period 2026-03-23 | 0001628280-26-021903 | | 2026-02-19 | 06:40 ET | [20-F](/filings/0001628280-26-009470.md) | Annual report of a foreign private issuer, period 2025-12-31 | 0001628280-26-009470 | | 2026-02-19 | 06:37 ET | [6-K](/filings/0001628280-26-009469.md) | Report of a foreign private issuer, period 2025-12-31 | 0001628280-26-009469 | | 2026-02-10 | 07:58 ET | [6-K](/filings/0001628280-26-006661.md) | Report of a foreign private issuer, period 2026-02-10 | 0001628280-26-006661 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-009470.md), filed Feb 19, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 313216 - Tickers: PHG, RYLPF - Exchange: NYSE - SIC code: 3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus - State of incorporation: P7 - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.